Physician-Drugmaker Disputes Over Sunshine Act Reporting May Trigger CMS Audit

Drug Industry Daily
A A
Drugmakers that face multiple disputes with doctors over payments reported to the Centers for Medicaid and Medicare Services (CMS) under the Physician Payment Sunshine Act will likely face an audit by the agency.

To View This Article:

Login

Subscribe To Drug Industry Daily